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The current burden of >5 million deaths yearly is the focus of the Sustainable Development
Goal (SDG) to end preventable deaths of newborns and children under 5 years old by 2030.
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To accelerate progression toward this goal, data are needed that accurately quantify the
leading causes of death, so that interventions can target the common causes. By adding
postmortem pathology and microbiology studies to other available data, the Child Health
and Mortality Prevention Surveillance (CHAMPS) network provides comprehensive evalua-
tions of conditions leading to death, in contrast to standard methods that rely on data from
medical records and verbal autopsy and report only a single underlying condition. We ana-
lyzed CHAMPS data to characterize the value of considering multiple causes of death.
Methods and findings
We examined deaths identified from December 2016 through November 2020 from 7
CHAMPS sites (in Bangladesh, Ethiopia, Kenya, Mali, Mozambique, Sierra Leone, and
South Africa), including 741 neonatal, 278 infant, and 241 child <5 years deaths for which
results from Determination of Cause of Death (DeCoDe) panels were complete. DeCoDe
panelists included all conditions in the causal chain according to the ICD-10 guidelines and
assessed if prevention or effective management of the condition would have prevented the
death. We analyzed the distribution of all conditions listed as causal, including underlying,
antecedent, and immediate causes of death. Among 1,232 deaths with an underlying condi-
tion determined, we found a range of 0 to 6 (mean 1.5, IQR 0 to 2) additional conditions in the
causal chain leading to death. While pathology provides very helpful clues, we cannot always
be certain that conditions identified led to death or occurred in an agonal stage of death. For
neonates, preterm birth complications (most commonly respiratory distress syndrome) were
the most common underlying condition (n = 282, 38%); among those with preterm birth com-
plications, 256 (91%) had additional conditions in causal chains, including 184 (65%) with a
different preterm birth complication, 128 (45%) with neonatal sepsis, 69 (24%) with lower
respiratory infection (LRI), 60 (21%) with meningitis, and 25 (9%) with perinatal asphyxia/hyp-
oxia. Of the 278 infant deaths, 212 (79%) had�1 additional cause of death (CoD) beyond
the underlying cause. The 2 most common underlying conditions in infants were malnutrition
and congenital birth defects; LRI and sepsis were the most common additional conditions in
causal chains, each accounting for approximately half of deaths with either underlying condi-
tion. Of the 241 child deaths, 178 (75%) had�1 additional condition. Among 46 child deaths
with malnutrition as the underlying condition, all had�1 other condition in the causal chain,
most commonly sepsis, followed by LRI, malaria, and diarrheal disease. Including all posi-
tions in the causal chain for neonatal deaths resulted in 19-fold and 11-fold increases in attrib-
utable roles for meningitis and LRI, respectively. For infant deaths, the proportion caused by
meningitis and sepsis increased by 16-fold and 11-fold, respectively; for child deaths, sepsis
and LRI are increased 12-fold and 10-fold, respectively. While comprehensive CoD determi-
nations were done for a substantial number of deaths, there is potential for bias regarding
which deaths in surveillance areas underwent minimally invasive tissue sampling (MITS),
potentially reducing representativeness of findings.
Conclusions
Including conditions that appear anywhere in the causal chain, rather than considering
underlying condition alone, markedly changed the proportion of deaths attributed to various
diagnoses, especially LRI, sepsis, and meningitis. While CHAMPS methods cannot deter-
mine when 2 conditions cause death independently or may be synergistic, our findings
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suggest that considering the chain of events leading to death can better guide research and
prevention priorities aimed at reducing child deaths.
Author summary
Why was this study done?
• More than 5 million deaths occur annually in children <5 years of age globally, mostly
in low-income settings in Africa and South Asia.
• There is reason to believe that a substantial proportion of these deaths are preventable if
there were effective programs that target the most common causes of death.
What did the researchers do and find?
• We studied the causes of death in 7 sites in Africa and South Asia where child mortality
is high by conducting surveillance for mortality and then collecting samples of tissue
and other diagnostic specimens to perform pathology and diagnostic tests.
• In each country, a panel of clinical, laboratory, and epidemiological experts determined
underlying, intermediate, and immediate causes of death for each child by studying the
clinical data available before death, postmortem questionnaire surveys done with
parents of the deceased, and postmortem pathology and testing.
What do these findings mean?
• Up to now, most programs focus on a single cause of death (CoD) for each child
referred to as the underlying condition.
• However, the findings suggest that most deaths have multiple conditions that contribute
to death.
• Considering all of the conditions, rather than underlying condition alone, markedly
changed the proportion of deaths attributed to various diagnoses, especially lower respi-
ratory infection (LRI), sepsis, and meningitis.
• The findings suggest that considering the full chain of events leading to death can better
guide priorities for research and strategies for mortality prevention.
Introduction
An estimated 5.2 million children <5 years of age die each year [1]. Massive disparities under-
pin that figure: >4.3 million (83%) of these deaths occur in sub-Saharan Africa and South Asia
[1]. As large as these numbers are, they reflect a drop of an estimated 7 million child deaths
since 1990 [2]. Much of the decline in mortality has occurred in infants and children 1 to 5
years; consequently, neonatal deaths represent an increasing proportion of the mortality
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burden [3,4], estimated at 46% in 2019 [1]. The remaining childhood mortality burden and the
associated geographic and economic status–based disparities are the focus of Sustainable
Development Goal (SDG) 2030 objectives to “end preventable deaths of newborns and chil-
dren under 5” and to reduce child mortality to less than 25 deaths per 1,000 live births in each
country globally. To achieve these ambitious goals, data are needed that accurately quantify
the leading causes of death, so that interventions targeting the common causes of death can be
developed and implemented, especially in geographic locations that continue to experience
high child mortality.
Results from in-depth investigations of the conditions contributing to child deaths may
require new or modified modeling approaches to interpret and integrate the data within exist-
ing regional and global frameworks for calculating disease burden, including cause-specific
mortality burden, which are often relied upon to prioritize investments in interventions to
reduce mortality. Most burden of disease models work on a principle of one cause per death,
to ensure that the “sum of cause-specific mortality rates was identical to total age-specific mor-
tality rates,” as was stated in an early global disease burden report [5]. This approach became
convention so that the causes of death reported do not exceed the number of deaths and
because the sources of death information that enter into burden models, especially from low-
income countries, have traditionally been vital registration, sample registration, and verbal
autopsy data, sources that typically provide only a single underlying condition as the cause of
reported deaths [1,5]. Among the methodologies used to ascertain cause of death (CoD), those
derived from the verbal autopsy lack specificity with regard to most biological causes of death.
During the past decade, increasing use of postmortem specimens collected through mini-
mally invasive tissue sampling (MITS—formerly referred to as minimally invasive autopsy) are
illuminating the sequence of events leading to deaths in children [6–8]. Studies have illustrated
high resolution in elucidating CoD with greater accuracy than can be expected from verbal
autopsies [9] when postmortem pathology, microbiology, molecular, and other diagnostic test-
ing are employed, including identifying specific pathogens responsible for infectious disease–
associated deaths [10–12].
The Child Health and Mortality Prevention Surveillance (CHAMPS) network conducts
standardized mortality surveillance following standardized protocols in high child mortality
sites in 7 countries in Africa and South Asia [13]. This work includes detecting stillbirths and
deaths in children under 5 years old, obtaining family consent for postmortem studies, collect-
ing MITS specimens that undergo pathologic and diagnostic testing, and gathering verbal
autopsy and clinical data to fully describe events leading to death. The full set of data is
reviewed by a local panel to identify relevant conditions that led to each death, following ICD-
10 and ICD-10 PM procedures, in a standardized process referred to as Determination of
Cause of Death (DeCoDe) [14]. Evaluating all of the data collected, DeCoDe panels provide
the underlying CoD, and if present, a separate immediate CoD and causes of death that are
referred to as “antecedent or intermediate,” which are listed as ICD-10 codes between immedi-
ate and underlying. Each CoD report therefore provides a “causal chain,” shedding light onto
the complete pathway from the first event initiating the cascade of occurrences that lead to the
fatal outcome.
In contrast, mortality statistics have traditionally relied only on the underlying causes,
completely neglecting other components in the chain of events leading to death. DeCoDe pan-
els follow a fundamental counterfactual precept: For a cause to be listed in the causal chain, the
panel members must conclude that if that condition was prevented (regardless of whether an
effective prevention strategy currently exists) or effectively managed, the death would have
been prevented. Findings from the initial 2 years of data collection from the first 5 CHAMPS
sites to implement surveillance and postmortem studies demonstrated that most neonatal,
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infant, and childhood deaths had more than 1 condition in the causal chain, many of which
were preventable [15].
We reason that focusing on only the underlying condition misses critical factors, leading to
the deaths of children, thus, limiting the scope and potential of mortality prevention approaches,
including developing new prevention and treatment modalities, diagnostics, improved clinical
management, and specific strengthening of health systems. In this manuscript, we aimed to char-
acterize how identifying, quantifying, and characterizing all conditions in the causal chain
increases the potential for lives saved from interventions targeting leading causes of death when
compared to considering only the underlying condition. In short, we posit that including multi-
ple causes of death in burden models will present multiple ways to prevent death.
Methods
We analyzed CHAMPS CoD data from all 7 sites to characterize the distribution of conditions
that are listed as causes of death for neonates, infants (<28 days old), and children (12 months
to<60 months). Surveillance methods and inclusion criteria for CHAMPS enrollment for
MITS [13] have been described previously. Briefly, children who were<5 years of age at the
time of death and were residents of a catchment area were eligible for enrollment. Parents or
guardians were approached for consent for verbal autopsy and clinical chart abstraction; per-
mission was also sought for specimen collection and testing for children whose deaths were
identified within 24 hours of occurrence. The protocol was prospectively developed.
Site selection and characteristics have also been previously described [13]. Briefly, the
CHAMPS network consists of 7 sites in sub-Saharan Africa and South Asia, each with a geo-
graphically defined catchment area: Baliakandi and Faridpur, Bangladesh; Bamako (Djikoroni
Para and Banconi), Mali; Kersa and Harar, Ethiopia; Makeni (Bombali Shebora and Bombali
Siari Chiefdoms), Sierra Leone; Manhiça, Mozambique; Siaya (Karemo) and Kisumu (Man-
yatta), Kenya; and Soweto and Thembelihle, South Africa. Sites were selected based on a variety
of factors, including demonstrated mortality of greater than 50 deaths per 1,000 live births in
children less than 5 years old at the time of site selection (2015), willingness of the local lead
investigator to use a common, multisite protocol and to share data globally in real time, as well
as ecologic and geographic diversity: We set out to have a distribution of rural, peri-urban, and
urban (including informal settlement) sites, prevalence of HIV and malaria, and dispersed loca-
tions (geographically, to the degree possible) in sub-Saharan Africa. An additional key consider-
ation was the possibility for a strong relationship between the site and the local ministry of
health and/or national public health institute, to ensure that data collected contribute to
national public health policy and actions. In addition, limited history of studies to understand
disease burden were important components for selecting 2 sites (in Sierra Leone and Ethiopia).
Specimen collection and laboratory and pathology testing have also been described [15–
18]. The study protocol is available at https://champshealth.org/resources/. Briefly, following
written parental/guardian consent, trained CHAMPS technicians collected tissue specimens
via standardized needle biopsies from lungs, heart, brain, liver, and bone marrow. Technicians
also collected blood, cerebrospinal fluid (CSF), and nasopharyngeal and rectal swabs. Anthro-
pometric data and photographs are also collected during the procedure to evaluate nutritional
status and birth defects, respectively. Tissue specimens were reviewed by local and Centers for
Disease Control and Prevention (CDC) pathologists using routine histopathology and special
stains and immunohistochemistry [18]. Lung tissue, blood, CSF, and rectal and nasopharyn-
geal swabs were tested for 116 infectious pathogens using multiplexed TaqMan Array Cards
[18], and blood and CSF were cultured using standardized microbiological methods. Data
were abstracted from available clinical records (both child and maternal when applicable), and
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trained interviewers used appropriate language translations of the 2016 WHO verbal autopsy
instrument to interview caregivers of enrolled deceased children [13,19]. All data for each
deceased child from which MITS was collected were reviewed by DeCoDe panels [12] in each
country. These local panels consist of clinicians (pediatricians and obstetricians), laborator-
ians, and public health specialists and determine the causes of death, assigning the underlying,
antecedent (intermediate) and immediate causes of death with the appropriate ICD-10 codes
following WHO ICD-10 and WHO application of ICD-10 to deaths during the perinatal
period (ICD-PM) [19–21]. The ICD-10 codes are then grouped into broad categories based on
the Global Burden of Disease groupings [22].
A total of 4,355 deaths (excluding stillbirths) were identified with 3,539 enrolled across
CHAMPS sites from 5 December 2016 through 30 November 2020, including 2,823 that were
eligible for MITS (i.e., deaths identified within 24 hours of death in which the body was avail-
able and parents consented for the procedure) (Fig 1). Of these, MITS was done in 1,765
deaths and results from DeCoDe proceedings were available for 1,260 deaths, which repre-
sented the dataset used for this analysis. Stillbirths were excluded since the causes of death typi-
cally reflect maternal conditions.
We stratified analyses by deaths occurring during the first 27 days of life (neonates), from
28 days to<12 months of age (infants), and from 12 months to<60 months old (child). We
defined the causal chain of mortality for each death to include any condition that appears as
the underlying cause or was among antecedent or immediate cause categories, which, together,
can include multiple causes. We defined “preterm birth conditions” to include low birth
weight, hyaline membrane disease, necrotizing enterocolitis, and pneumothorax following the
Fig 1. Flowchart of enrollment of deaths among children 0 to less than 5 years of age in CHAMPS sites, deaths
with MITS procedure, and cases with CoDs determined by review panels (DeCoDe). Among 4,355 deaths eligible at
the 7 CHAMPS sites, MITS was done for 1,765, and DeCoDe results were available for these analyses for 1,260 deaths.
CAU : AnabbreviationlisthasbeencompiledforthoseusedthroughoutFig1:Pleaseverifythatallentriesarecorrect:HAMPS, Child Health and Mortality Preven ion Surveillance; CoD, cause of death; DeCoDe, Determination of
Cause of Death; MITS, minimally invasive tissue sampling.
https://doi.org/10.1371/journal.pmed.1003814.g001
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Global Burden of Disease groupings described above. For neonates with more than 1 type of
preterm birth complication, the DeCoDe panels categorized them as having a preterm birth
condition as the underlying CoD along with an additional preterm birth condition as either an
antecedent or immediate cause. Similarly, other groupings, such as neonatal sepsis and perina-
tal asphyxia/hypoxia, could be found multiple times in the causal chain for the same death if
different etiologies (i.e., multipathogen sepsis) or conditions that fell within that group were
identified for that case.
We evaluated proportions of deaths by age category associated with each of the conditions
listed in the causal chain and evaluated the additional causes in the causal chain for each
underlying condition. Finally, we assessed the “attribution gain” (shown as x-fold increases)
for each CoD when a causal chain assessment was used for each death by aggregating deaths
by age group and comparing with the number of deaths that would be attributed to each cause
when relying on underlying condition alone. We used medians, counts, and percentages to
summarize data and used χ2 tests as appropriate to describe significant differences among
number of causes. All analyses were conducted in SAS v 9.4.
Parents or guardians of deceased children provided written informed consent prior to col-
lection of data, specimens, or information on living people (i.e., mothers). Ethics committees
overseeing investigators at each site and at Emory University approved overall and site-specific
protocols (Emory Institutional Review Board [IRBAU : PleasenotethatIRBhasbeendefinedasInstitutionalReviewBoardinthesentenceEthicscommitteesoverseeinginvestigatorsat::::Pleasecheckandcorrectifnecessary:] #: 00091706). CDC relied for review on
the Emory University committee for the overall protocol and on appropriate site ethical review
committees where CDC staff were directly engaged at the site. The protocol is available at
https://champshealth.org/wp-content/uploads/2021/08/CHAMPS-Mortality-Surveillance-
Protocol-v1.3.pdf (S1 Protocol). Data can be accessed at champshealth.org, and requests can
be made at the site to access additional datasets. Datasets are publicly available at (CHAMPS,
2021, “CHAMPS De-identified Dataset”; https://dataverse.unc.edu/dataset.xhtml?persistent
Id=doi:10.15139/S3/PMAAWG). This study is reported as per the Strengthening the Reporting
of Observational Studies in Epidemiology (STROBE) guideline (S1 Checklist).
Results
Among 1,260 neonatal, infant, and child deaths, a CoD was determined in 1,232; 28 (2%) were
considered undetermined after review of all data. Of these 1,232 deaths, the DeCoDe process
identified 51 separate underlying disease diagnoses (Tables 1–3). The number of additional
conditions in the causal chain for each death ranged from 0 to 6, with a median of 1 (mean of
1.5, IQR 0 to 2) additional condition. About 1 in 3 (31%, 223/726) deaths in the neonatal age
group were attributed to only an underlying cause without any additional causes, compared to
21% (56/268) and 25% (60/238), respectively, deaths among infants and children. The number
of conditions in the causal chain is greater for deaths occurring in a health facility [mean 2.57,
95% CI (2.48, 2.65)] when compared with community deaths [mean 1.9, 95% CI (1.76 to 2.12)]
(p< 0.001), regardless of age (Table 4). Among the top 5 underlying conditions, 4 (preterm
birth complications, perinatal asphyxia, congenital birth defects, and neonatal sepsis) predom-
inantly affect neonatal outcomes; malnutrition was listed as the underlying condition for 84
deaths (7% of all deaths and 17% of non-neonatal deaths). Other common (>10%) underlying
conditions affecting under-fives in at least 1 age category included HIV, lower respiratory
infections (LRIs), malaria, diarrheal diseases, congenital infection, and injury.
Neonatal deaths
Among 741 neonatal deaths, DeCoDe panels identified 27 different underlying disease diagno-
ses (Table 1). The most common were preterm birth complications (282, 38%), perinatal
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asphyxia (192, 26%), neonatal sepsis (79, 11%), and congenital birth defects (68, 9%). Exclud-
ing 15 deaths for which the CoD was undetermined, 503 (69%) deaths had 1 or more CoD
beyond the underlying cause (mean = 1.4, IQR 0 to 2). Preterm birth complications include
low birth weight, respiratory distress syndrome, prematurity, and bronchopulmonary dyspla-
sia; of those neonatal deaths with preterm birth complications listed anywhere in the causal
chain, 67% (234/347) had respiratory distress syndrome.
Among 282 neonatal deaths with preterm birth complications as the underlying condition,
256 (91%) had additional conditions in the causal chain, including 184 (65%) with another
type of preterm birth complication (Table 5). Nearly half (137, 49%) of neonatal deaths with
preterm birth complications as the underlying cause had other conditions not related to pre-
term birth complications within the causal chain. Indeed, more than half of the deaths with
preterm birth complications or congenital birth defects as underlying conditions had�3 other
diagnoses in the causal chain (Table 5). The most common conditions listed as immediate or
antecedent causes (other than preterm birth complications) included neonatal sepsis [128
(45%)], LRI [69 (24%)], meningitis [60 (21%)], and perinatal asphyxia/hypoxia [25 (9%)]
(Table 6). When known, the most common maternal factors associated with deaths due to pre-
term birth complications included hypertension (58/273, 21%), multiple gestation (39/273,
14%), and placental separation/antepartum hemorrhage (26/273, 10%). For deaths due to peri-
natal asphyxia, the most common maternal factors included obstructed labor and other com-
plications of labor and delivery and placental separation/antepartum hemorrhage.
Infant deaths
Among 278 infant deaths, 31 different underlying disease diagnoses were identified (Table 2).
Five conditions accounted for>50% of the underlying diagnoses, including malnutrition (38,
14%), congenital birth defects (37, 13%), LRI (n = 32; 12%), preterm birth complications (32,
12%), and HIV (30, 11%). Excluding 11 deaths for which the causes of death was undetermined
Table 1. Underlying causes for 741 neonatal deaths.
Underlying cause # of deaths %
Neonatal preterm birth complications 282 38%
Perinatal asphyxia/hypoxia 192 26%
Neonatal sepsis 79 11%
Congenital birth defects 68 9%
Congenital infection 27 4%
Neonatal aspiration syndromes 16 2%
Other neonatal disorders 15 2%
LRIs 11 2%
Neonatal encephalopathy 9 1%
Meningitis 5 0.7%
Chorioamnionitis and membrane complications� 3 0.4%
Syphilis 2 0.3%
All others (with only 1 case each) 17 2%
Undetermined 15 2%
Total 741
� Placenta was rarely obtained and examined; however, clinical records were considered when making the diagnosis
of chorioamnionitis.
LRI, lower respiratory infection.AU : AbbreviationlistshavebeencompiledforthoseusedthroughoutTables1   3;6   8;and10   13:Pleaseverifythatallentriesarecorrect:
https://doi.org/10.1371/journal.pmed.1003814.t001
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resulted in 268 deaths with at least 1 cause determined; of these, 212 (79%) infant deaths had at
least 1 additional CoD beyond the underlying cause (mean = 1.6; IQR = 1 to 3).
Among the 38 infant deaths with malnutrition as the underlying condition, 37 (97%) had a
least 1 other condition in the causal chain (Table 7); the number of conditions in the causal
chain ranged from 1 to 4 (median = 2, mean = 1.7). The most common conditions listed as
immediate or intermediate causes included sepsis (19, 50%) and LRI (19, 50%) (Table 8).
Among the 37 infant deaths with congenital birth defects as the underlying condition, 36
(97%) had at least 1 other condition in the causal chain (Table 7); the most common condi-
tions in the causal chains for these deaths included sepsis (20, 54%), LRI (18, 49%), and menin-
gitis (5, 14%) (Table 8).
Child deaths
For 241 child (age 1 to 5) deaths, 4 conditions accounted for>50% of the underlying causes of
death: malnutrition (46, 19%), malaria (39, 16%), HIV (32, 13%), and injury (20, 10%)
(Table 1). Excluding 3 cases for which the CoD was undetermined resulted in 238 child deaths
with at least 1 CoD determined; of these, 178 (75%) deaths had at least 1 CoD beyond the
underlying cause (mean = 1.5; IQR = 0 to 2).
Among the 46 child deaths with malnutrition as the underlying condition, all had at least 1
other condition in the causal chain (Table 9); the most common conditions listed as immediate
Table 2. Underlying causes for 278 infant deaths.
Underlying cause # of deaths %
Malnutrition 38 14%
Congenital birth defects 37 13%
LRIs 32 12%
Neonatal preterm birth complications 32 12%
HIV 30 11%




Other respiratory disease 5 2%
Other infections 5 2%
Sudden infant death syndrome 4 1%
Other neurological disorders 4 1%
Other neonatal disorders 4 1%




Paralytic ileus and intestinal obstruction 2 0.7%
Liver disease 2 0.7%
Other skin and subcutaneous diseases 2 0.7%
All other causes (with 1 each) 12 4%
Undetermined 10 4%
Total 278
LRI, lower respiratory infection.
https://doi.org/10.1371/journal.pmed.1003814.t002
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or underlying causes included sepsis, LRI, malaria, and diarrheal disease (Table 10). While all
sources of CHAMPS data contributed to identifying to multiple causes of death, pathologic
findings, including immunohistochemistry, were often helpful for recognition and confirming
them, as was the case for a child death due to both cerebral malaria and pneumococcal pneu-
monia (Fig 2).
Assessing the causal chain for mortality
Including conditions that appear anywhere in the causal chain (rather than underlying condi-
tion alone) markedly changed the proportion of deaths attributed for a variety of conditions,
especially LRI, sepsis, and meningitis (Tables 11–13). For neonatal deaths, for example, includ-
ing all positions in the causal chain resulted in 19-fold and 11-fold increases in attributable
roles for meningitis and LRI, respectively (Table 11). For infant deaths, the proportion caused
Table 3. Underlying causes for 241 child deaths.





Congenital birth defects 18 7%
Diarrheal diseases 15 6%
LRIs 10 4%
Other respiratory disease 8 3%
Sepsis 6 2%
Other infections 5 2%
Meningitis 3 1%




Other endocrine, metabolic, blood, and immune disorders 3 1%
Poisoning 2 0.8%





LRI, lower respiratory infection.
https://doi.org/10.1371/journal.pmed.1003814.t003
Table 4. Mean number of conditions in the causal chain for each age group by whether the death occurred in the community or in a healthcare facility.
Age groupAU : PleasenotethatasperPLOSstyle; italicsshouldnotbeusedforemphasis:Community Facility Overall (for age group)
N Mean (95% CI) N Mean (95% CI) N Mean (95% CI)
Neonates 44 1.7 (1.3, 2.1) 697 2.4 (2.3, 2.5) 741 2.4 (2.3, 2.5)
Infant 82 1.9 (1.6, 2.2) 196 2.9 (2.7, 3.1) 278 2.6 (2.4, 2.8)
Child 75 2.1 (1.8, 2.4) 166 2.7 (2.5, 2.9) 241 2.5 (2.4, 2.7)
TOTAL 201 1.9 (1.8, 2.1) 1,059 2.6 (2.5, 2.7) 1,260 2.5 (2.4, 2.5)
https://doi.org/10.1371/journal.pmed.1003814.t004
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by meningitis and sepsis increased by 16-fold and 11-fold, respectively (Table 12); sepsis and
LRI are increased 12-fold and 10-fold, respectively, for child deaths (Table 13).
Discussion
Interventions targeting the common causes of neonatal, infant, and child deaths are needed to
achieve SDG 2030 goals on reducing child mortality. A salient finding of our analyses of data
from CHAMPS is the degree to which considering only the underlying CoD underestimates the
role of several conditions in the mortality causal chain. The analyses showed that LRI, sepsis,
and meningitis were the most underestimated conditions, depending on the age group; LRI was
underestimated in all 3 age groups. Focusing on underlying conditions alone, as would be the
case with most global burden of disease reports, 1.5%, 15%, and 4% of deaths in neonates,
infants, and children, respectively, would be described as being due to LRI. However, if we con-
sider LRI appearing anywhere within the causal chain, LRI would be associated with 17%, 66%,
and 40% of deaths in neonates, infants, and children, respectively. That represents a range of
4.4- to 11.5-fold increases in the proportion of deaths in which the DeCoDe panel judged that
preventing LRI would have averted death. In settings where resources to implement strategies






complications (n = 282)
Perinatal asphyxia/




defects (n = 68)
Congenital
infection (n = 27)
All other
causes (n = 78)
Total
(n = 726)
0 26 (9%) 103 (54%) 36 (46%) 20 (29%) 4 (15%) 34 (44%) 223 (31%)
1 82 (29%) 51 (27%) 16 (20%) 20 (29%) 9 (33%) 18 (23%) 196 (27%)
2 77 (27%) 28 (15%) 15 (19%) 12 (18%) 7 (26%) 14 (18%) 153 (21%)
3+ 97 (34%) 10 (5%) 12 (15%) 16 (24%) 7 (26%) 12 (15%) 154 (21%)
https://doi.org/10.1371/journal.pmed.1003814.t005






complications (n = 282)
Perinatal asphyxia/




defects (n = 68)
Congenital





184 (65%) 18 (9%) 17 (22%) 12 (18%) 8 (30%) 10 (13%)
Low birth weight 12 (4%) 9 (5%) 15 (19%) 5 (7%) 7 (26%) 15 (19%)
Respiratory distress
syndrome
162 (57%) 11 (6%) 9 (11%) 3 (4%) 4 (15%) 18 (23%)
Pulmonary hemorrhage 10 (4%) 0 1 (1%) 1 (1%) 0 0
Primary atelectasis 8 (3%) 0 1 (1%) 4 (6%) 0 0
Perinatal asphyxia/hypoxia 25 (9%) 6 (3%) 11 (14%) 9 (13%) 6 (22%) 8 (10%)
LRIs 69 (24%) 10 (5%) 7 (9%) 17 (25%) 4 (15%) 6 (8%)
Meningitis/encephalitis 60 (21%) 3 (2%) 14 (18%) 6 (9%) 1 (4%) 5 (6%)
� Excluding cases that only had 1 cause (which would be listed as the underlying condition) in the causal chain.
† These conditions appear anywhere else (other than as an underlying condition) in the causal chain (i.e., as immediate or antecedent); thus, a single case in a column
with that underlying cause can be counted in multiple rows if there is more than 1 contributing condition within that category (like with preterm birth conditions,
which have multiple contributing conditions) in the causal chain.
¥ For multiple cases, there was >1 preterm birth complication listed as antecedent or immediate.
CHAMPS, Child Health and Mortality Prevention Surveillance; CoD, cause of death; LRI, lower respiratory infection.
https://doi.org/10.1371/journal.pmed.1003814.t006
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to prevent or improve management are scarce, the findings of this work could help to clarify the
potential value of reducing the impact of LRI on mortality, for example.
Sepsis and meningitis, both treatable and potentially preventable, represent 2 other fre-
quently underestimated causes of death when only 1 cause is counted per death. We identified
a>11-fold increase in sepsis-associated deaths when immediate and antecedent causes are
considered for infants and children and a>3-fold increase for neonates. If underlying condi-
tion was only used, meningitis would be a massively underappreciated CoD in neonates and
infants (>16-fold increase when immediate and antecedent causes are considered).
Previous work on mortality burden has focused on 1 cause per death and has not included
postmortem pathological data, often relying on verbal autopsy, and limited antemortem clini-
cal data [1,5]. The importance of recognizing all conditions in the causal chain is demonstrated
when considering preterm birth complications. Preterm birth is well recognized as a cause of
neonatal death [23,24]. Our findings suggest that a significant proportion of neonatal deaths in
preterm babies had sepsis, LRI, and meningitis in the causal chain. In wealthy countries, well-
managed preterm births survive the neonatal period and the babies often grow to lead normal,
productive lives, highlighting the value of optimized clinical management in preterm babies.
Improved diagnostic tools, therapeutics, and prevention strategies to reduce fatal sepsis, pneu-
monia, and meningitis in preterm babies have the potential of dramatically reducing mortality
and improving outcomes. In addition, recognizing multiple maternal conditions that contrib-
ute to preterm births will help to focus on strategies for maternal care to improve birth out-
comes. All of the above considerations are relevant for health system strengthening strategies,
Table 7. Number of conditions in causal chain: Infants.

















0 1 (3%) 1 (3%) 10 (31%) 0 2 (7%) 42 (42%) 56 (21%)
1 17 (45%) 9 (24%) 17 (53%) 4 (13%) 9 (30%) 28 (28%) 84(31%)
2 13 (34%) 13 (35%) 4 (13%) 6 (19%) 7 (23%) 14 (14%) 57 (21%)
3+ 7 (18%) 14 (38%) 1 (3%) 22 (69%) 12 (40%) 15 (15%) 71 (26%)
LRI, lower respiratory infection.
https://doi.org/10.1371/journal.pmed.1003814.t007

















LRIs 19 (50%) 18 (49%) 6 (19%) 19 (59%) 22 (73%) 30 (30%)
Sepsis 19 (50%) 20 (54%) 12 (38%) 24 (75%) 12 (40%) 25 (30%)
Meningitis/encephalitis 2 (5%) 5 (14%) 3 (9%) 7 (22%) 3 (10%) 13 (13%)
Other infections 3 (8%) 4 (11%) 1 (3%) 4 (13%) 8 (27%) 3 (3%)
Diarrheal diseases 6 (16%) 0 (0%) 2 (6%) 1 (3%) 3 (10%) 2 (2%)
� Excluding cases that only had 1 cause (which would be listed as the underlying condition) in the causal chain.
† These conditions appear anywhere else (other than as an underlying condition) in the causal chain (i.e., as immediate or antecedent); thus, a single case in a column
with that underlying cause can be counted within multiple rows if there is more than 1 contributing condition within that category (like if there are >1 specific causes of
LRIs, such as pneumococcal and Klebsiella etiologies) in the causal chain.
CHAMPS, Child Health and Mortality Prevention Surveillance; CoD, cause of death; LRI, lower respiratory infection.
https://doi.org/10.1371/journal.pmed.1003814.t008
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including infection control, antimicrobial drug stewardship, as well as support to critically ill
infants, and research and development for better diagnostic tools, therapeutics, and vaccines
[25]. An example of this potential is that CHAMPS has shown that sepsis (as well as LRI and
meningitis) due to Klebsiella pneumoniae across CHAMPS sites and Acinetobacter baumannii
(nosocomially transmitted predominantly in one site), often highly drug resistant, are impor-
tant causes of neonatal and infant mortality [15]. This information has contributed to priori-
tizing diagnostic development for illness associated with these 2 pathogens, as well as
evaluating A. baumannii monoclonal antibody therapeutics [26] and the potential for K. pneu-
moniae vaccines [25,27].
Further information on causes of LRI associated with mortality will also help with prioritiz-
ing new diagnostic and vaccine development, as well as basic lifesaving care (for example, use
of oxygen). While ongoing data collection will provide more detail, early published data from
CHAMPS have shown key contributions from bacterial pathogens like K. pneumoniae, Strep-
tococcus pneumoniae, and A. baumannii, as well as among viral pathogens (multiple pathogens
in causal chains for individual patients), especially respiratory syncytial virus, with varying
contributions of each of these pathogens by age group and by whether the infections were
acquired during hospitalization [15]. Like with syndromes and broad conditions (as shown in
our current analyses), causal pathogens are found across the causal chain, often with>1 patho-
gen linked to mortality in a single case [15], further highlighting the importance of looking
beyond underlying conditions when focusing on preventing mortality.
Age-specific analyses of child mortality are important for considering optimal immunization
approaches and vaccine development; for instance, for causes of LRI that have impact during the
Table 9. Number of conditions in causal chain for child deaths.

















0 0 22 (56%) 1 (3%) 6 (29%) 0 31 (39%) 60 (25%)
1 12 (26%) 7 (18%) 10 (31%) 7 (33%) 6 (33%) 23 (29%) 65 (27%)
2 14 (30%) 5 (13%) 15 (47%) 7 (33%) 5 (28%) 10 (13%) 56 (24%)
3+ 20 (43%) 5 (13%) 6 (19%) 3 (14%) 7 (39%) 16 (20%) 57 (24%)
https://doi.org/10.1371/journal.pmed.1003814.t009
Table 10. Most common additional conditions (antecedent and immediate CoD) in the causal chain for the 5 leading underlying causes of child deaths in
CHAMPS.�















LRIs 25 (54%) 4 (10%) 16 (50%) 7 (30%) 11 (61%) 24 (30%)
Sepsis 28 (61%) 4 (10%) 14 (44%) 11 (48%) 3 (17%) 18 (23%)
Malaria 13 (28%) 2 (5%) 7 (22%) 2 (9%) 3 (17%) 2 (3%)
Other respiratory disease 1 (2%) 7 (18%) 2 (6%) 1 (4%) 5 (28%) 7 (9%)
Diarrheal diseases 11 (24%) 1 (3%) 6 (19%) 0 (0%) 0 (0%) 3 (4%)
� Excluding cases that only had 1 cause (which would be listed as the underlying condition) in the causal chain.
† These conditions appear anywhere else (other than as an underlying condition) in the causal chain (i.e., as immediate or antecedent); thus, a single case in a column
with that underlying cause can be counted within multiple rows if there is more than 1 contributing condition within that category (in this for “all other causes,” there
would be multiple specific conditions that appear as immediate or antecedent causes of death) in the causal chain.
CHAMPS, Child Health and Mortality Prevention Surveillance; CoD, cause of death; LRI, lower respiratory infection.
https://doi.org/10.1371/journal.pmed.1003814.t010
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neonatal period (like respiratory syncytial virus, RAU : PleasenotethatRSVhasbeendefinedasrespiratorysyncytialvirusinthesentenceAge   specificanalysesofchildmortality::::Pleasecheckandcorrectifnecessary:SV), maternal immunization (or use of monoclo-
nal antibodies at birth) would be the approach to evaluate and optimize, given our current state of
understanding of immune activation and responses. Information from the entire causal chain of
mortality would be critical for consideration; if underlying diseases were the only focus and there
was inability to identify causative pathogens, prioritization would be more subjective, relying on
conjecture or extrapolations from data from clinical surveillance and testing of ill children.
The data most commonly used to prioritize targets for research and public health program
strategies are global, regional, and local burden of disease reports [1,2,5]. They have provided
foci for stakeholders to support programs to improve the health of children. Because existing
reports include 1 death per child so that the total number of deaths reported equals 100% of
deaths, the impact of conditions that contribute substantively to death when there are multiple
causes is highly underestimated. Furthermore, CoD determinations, often based on hospital
discharge data and verbal autopsy, can be associated with substantial misclassification. As a
result, the utility of existing data for prioritizing mortality prevention interventions and
research and development is dramatically reduced.
Fig 2. On the left, Plasmodium falciparum are visualized via staining by immunohistochemistry within red blood cells in small blood vessels (arrows) in the brain. On the
right, clusters of Streptococcus pneumoniae bacteria are seen in the lung of the same child by immunohistochemistry (arrow pointing to one cluster).
https://doi.org/10.1371/journal.pmed.1003814.g002
Table 11. Increases in estimated contribution of leading causes of death when considering any location in the causal chain compared to only using the underlying
CoD: Neonate (n = 726).
Condition n (%) only as underlying condition n (%) anywhere in causal chain Fold increase
Meningitis 5 (0.7%) 94 (13%) 18.6
LRIs 11 (1.5%) 124 (17%) 11.3
Neonatal encephalopathy 9 (1.2%) 54 (7%) 5.8
Neonatal sepsis 79 (11%) 278 (37%) 3.4
Neonatal aspiration syndrome 16 (2%) 41 (5%) 2.5
Congenital infection 27 (4%) 59 (8%) 2.0
Perinatal asphyxia/hypoxia 192 (26%) 251 (34%) 1.3
Preterm birth complications 282 (38%) 347 (47%) 1.2
Congenital birth defects 68 (9%) 83 (11%) 1.2
CoD, cause of death; LRI, lower respiratory infection.
https://doi.org/10.1371/journal.pmed.1003814.t011
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By using systematic collection and laboratory and pathologic evaluation of postmortem
specimens, combined with review of available clinical data and verbal autopsies, the specificity
of CoD reports increases [15], demonstrating that more than 1 condition usually contributes
to death. Thus, focusing on 1 CoD severely limits the scope and potential impact of prevention
programs and research and development into approaches that would target high-impact
conditions.
We recognize a number of limitations in these analyses and the need for qualifications in
our interpretations. Among 4,355 deaths that were detected within CHAMPS sites during the
study period, MITS was done on 1,765. Nearly 35% (1,532/4,355) of deaths were detected after
the time period allowed for MITS or burial had occurred; for deaths meeting criteria for
MITS, parental consent was given in 63%. While the findings of this report represent a sub-
stantial number of deaths that have undergone comprehensive CoD determinations, there is a
potential for bias for which deaths underwent MITS, which potentially reduces the representa-
tiveness of the findings. Likewise, while CHAMPS implemented a systematic site selection pro-
cess with representativeness of high child mortality areas as an objective, given the variability
of factors influencing child mortality, adjustments or ranges may need to be used in non-
CHAMPS locations and in low- and middle-income countries with lower rates for child mor-
tality (which may have fewer deaths with infectious diseases in causal chains).
We do not systematically collect social determinants of health (via “social autopsy”) [28] in
all sites. Thus, DeCoDe panels do not include social and health system–associated contributors
to death (like extreme poverty, poor obstetric care, availability of safe water and hygiene, and
limited access to clinical care) in causal chains. Collecting such data in a standard form is
under consideration for CHAMPS. We are currently not able to determine a causal framework
Table 13. Increases in estimated contribution of leading causes of death when considering any location in the causal chain compared to only using the underlying
CoD: Child (n = 238).
Condition n (%) only as underlying condition n (%) anywhere in causal chain Fold increase
Sepsis 6 (3%) 84 (35%) 11.5
LRIs 10 (4%) 97 (40%) 10.0
Meningitis 3 (1%) 15 (6%) 3.5
Diarrheal diseases 15 (6%) 35 (14%) 2.3
Malnutrition 46 (19%) 66 (27%) 1.4
Malaria 39 (16%) 66 (27%) 1.7
Congenital birth defects 18 (7%) 21 (9%) 1.3
CoD, cause of death; LRI, lower respiratory infection.
https://doi.org/10.1371/journal.pmed.1003814.t013
Table 12. Increases in estimated contribution of leading causes of death when considering any location in the causal chain compared to only using the underlying
CoD: Infant (n = 268).
Condition n (%) only as underlying condition n (%) anywhere in causal chain Fold increase
Meningitis 2 (1%) 35 (16%) 16.1
Sepsis 11 (5%) 119 (56%) 11.2
LRIs 32(15%) 140 (66%) 4.4
Diarrheal diseases 18 (8%) 31 (15%) 1.9
Malnutrition 38 (18%) 54 (25%) 1.4
Congenital birth defects 37 (17%) 40 (19%) 1.1
CoD, cause of death; LRI, lower respiratory infection.
https://doi.org/10.1371/journal.pmed.1003814.t012
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for multiple causes of death, including whether 2 conditions cause death independently or
whether they are synergistic with each other in leading to death. While the DeCoDe panels
make a judgment that preventing or successfully managing each condition in the causal chain
would have averted death, it is inevitable that at least some conditions occur after the child’s
initial condition has worsened to a point that saving the life would be impossible even if those
secondary conditions were treated optimally. As an example, a child near death from severe
birth asphyxia might develop LRI, which accelerates the timing of death; ultimately, the imme-
diate CoD might be determined to be LRI. Thus, the preventable burden will be somewhat
overestimated for a proportion of conditions, when using the entire causal chain. CHAMPS is
attempting to develop procedures to systematically determine conditions that are “agonal” ver-
sus truly causal, particularly challenging for deaths occurring outside of clinical settings.
Also, in some patients, sepsis, meningitis, and LRI in the causal chain reflect the same ill-
ness, during which a pathogen moves from the bloodstream to tissues or vice versa. In such
cases of invasive infection, the same intervention (a pathogen-specific intervention, for exam-
ple) would potentially prevent multiple conditions in the causal chain. However, 57% of such
cases with>2 of the above syndromes had different pathogens responsible for the coexisting
syndromes; 73% of children had sepsis, LRI, and/or meningitis caused by different pathogens,
followed by 69% in infants and 38% in neonates.
In conclusion, the findings of this report provide insights on how public health action, clini-
cal management, and research and priorities for the development of diagnostic, prevention,
and treatment tools can be affected by considering the multiple conditions that cause death
identified when comprehensive postmortem surveillance and investigation takes place. As
data accumulate from CHAMPS sites, these insights will become more granular at the patho-
gen level, by region and by a variety of other factors including specifics on settings (such as
hospital or community) for exposure prior to death. Emerging child mortality data from high
mortality areas need to be continuously assessed and translated into lifesaving action to
approach SDG 2030 child mortality goals.
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